The antiviral therapy Paxlovid remains effective in preventing severe illness from COVID-19 even when faced with new variants. Here's what to know about how Paxlovid works when faced with the virus that causes COVID-19.
The US health regulator s staff reviewers said on Tuesday data from Pfizer s COVID-19 drug trials support its use in adults at high risk of progressing to severe disease, bringing the pill closer to a full approval.
COVID-19 continues to hit seniors with disproportionate severity. Experts say Paxlovid is an effective therapy that is being underprescribed for people 65 and older.
COVID-19 continues to hit seniors with disproportionate severity. Experts say Paxlovid is an effective therapy that is being underprescribed for people 65 and older.
Paxlovid, an antiviral treatment for people at high risk of severe disease who have mild to moderate cases of COVID-19, is effective against the latest COVID-19 variant. Experts recommend that people at high risk figure out how to access the drug and any effect it may have on their current medications before they contract COVID.